Feature Reviews in Cardiovascular Diseases

Dear Colleagues,

Despite the progress made in the prevention and treatment of cardiovascular diseases, the number of hospital admissions, healthcare spending, and mortality from cardiovascular causes still rank first in developed and developing countries. However, it must be admitted that cardiovascular diseases are a branch of medicine in which the greatest progress is made every year. Maybe we missed something? One of the topics on which a lot of work has been carried out is heart failure, which is the endpoint of the vast majority of cardiac pathologies. While the situation is sufficiently defined, also from a therapeutic point of view, for HF with reduced ejection fraction (HFrEF), unfortunately this is not the case for HF with preserved EF (EFpEF), which has been seen to have a prevalence of approximately 50% of forms of HF. Albeit lacking, however, there has been considerable progress both in the knowledge of the pathophysiological mechanisms and in the therapeutic approach of this form of HF. In light of these developments, we have proposed this Special Issue entitled "Feature Reviews in Cardiovascular Diseases". It aims to collect the newest and most significant data on cardiovascular research, both in the field of cardiovascular prevention and mechanisms and on therapeutic innovations such as inhibitors of SGLT2 receptors and GLP1 receptor agonists, which have given positive results on adverse cardiovascular outcomes, even regardless of the presence of diabetes.

Dr. Serafino Fazio
Dr. Arturo Cesaro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.